脐带间充质干细胞及其条件培养基对脓毒症小鼠肠道菌群的调节作用
该研究将28只6至8周龄雌性C57BL/6J小鼠随机分为假手术组、盲肠结扎穿孔(CLP)脓毒症模型组、脓毒症+间充质干细胞(MSC)治疗组和脓毒症+MSC条件培养基(MSC-CM)治疗组,每组7只。CLP后6小时经腹腔注射0.2 mL 1×10^6 MSC或0.2 mL浓缩MSC-CM,假手术组和模型组给予0.2 mL无菌磷酸盐缓冲液。结果显示MSC和MSC-CM均可减轻肺和结肠病理损伤、增加结肠长度、降低血清IL-1β、降低F4/80+腹腔巨噬细胞比例、升高F4/80+CD206+抗炎腹腔巨噬细胞比例、提高肠道菌群α多样性sobs指数,且MSC-CM效果更显著(均P<0.05)。作者认为MSC-CM较MSC具有更优优势。
要点
- 脓毒症小鼠CLP后6小时腹腔注射MSC-CM,结肠长度增至6.87±0.18 cm、血清IL-1β降至343.20±23.61 ng/L,均优于CLP组的6.00±0.26 cm和432.70±17.68 ng/L(P<0.05)。
- MSC-CM使F4/80+CD206+抗炎腹腔巨噬细胞比例升至(66.38±4.73)%,高于MSC组的(52.73±5.02)%和CLP组的(45.25±6.75)%(P<0.05)。
- MSC-CM使肠道菌群α多样性sobs指数升至214.00±31.18,高于MSC组的182.50±16.35和CLP组的118.50±23.25(P<0.05)。
- MSC治疗也可增加结肠长度至6.53±0.27 cm、降低IL-1β至382.10±16.93 ng/L、降低F4/80+比例至(47.65±3.93)%、升高F4/80+CD206+比例至(52.73±5.02)%(均P<0.05)。
- MSC和MSC-CM均使肠道菌群物种组成重建,并观察到与转录、次级代谢物生物合成、转运和分解代谢、碳水化合物转运和代谢、信号转导相关的功能菌群相对丰度呈增加趋势。
适用人群与场景
- 6至8周龄雌性C57BL/6J小鼠,共28只,随机分为4组,每组7只。
- 脓毒症模型通过盲肠结扎穿孔(CLP)建立;假手术组不进行CLP,其余操作同CLP组。
处置流程与药物剂量
- CLP后6小时,CLP+MSC组经腹腔注射0.2 mL 1×10^6 MSC。
- CLP后6小时,CLP+MSC-CM组经腹腔注射0.2 mL浓缩MSC-CM。
- 假手术组和CLP组经腹腔注射0.2 mL无菌磷酸盐缓冲液(PBS)。
研究设计与关键结果
- 研究类型为动物实验;28只6至8周龄雌性C57BL/6J小鼠随机分为假手术组、CLP组、CLP+MSC组和CLP+MSC-CM组,每组7只。
- 与假手术组比较,CLP组肺和结肠出现显著炎症损伤,结肠长度缩短(cm:6.00±0.26 vs. 7.11±0.09),血清IL-1β升高(ng/L:432.70±17.68 vs. 353.70±17.01),F4/80+腹腔巨噬细胞比例升高[(68.25±3.41)% vs. (50.84±4.98)%],F4/80+CD206+抗炎腹腔巨噬细胞比例降低[(45.25±6.75)% vs. (66.66±3.36)%],肠道菌群α多样性sobs指数降低(118.50±23.25 vs. 255.70±6.87),物种组成结构改变,与转录、次级代谢物生物合成、转运和分解代谢、碳水化合物转运和代谢、信号转导相关的功能菌群相对丰度显著降低(均P<0.05)。
- 与CLP组比较,MSC或MSC-CM治疗后肺和结肠病理损伤不同程度减轻,结肠长度增加(cm:6.53±0.27、6.87±0.18 vs. 6.00±0.26),血清IL-1β降低(ng/L:382.10±16.93、343.20±23.61 vs. 432.70±17.68),F4/80+腹腔巨噬细胞比例降低[(47.65±3.93)%、(48.68±2.51)% vs. (68.25±3.41)%],F4/80+CD206+抗炎腹腔巨噬细胞比例升高[(52.73±5.02)%、(66.38±4.73)% vs. (45.25±6.75)%],肠道菌群α多样性sobs指数升高(182.50±16.35、214.00±31.18 vs. 118.50±23.25),且MSC-CM效果更显著(均P<0.05)。
- MSC和MSC-CM治疗后肠道菌群物种组成重建,并观察到功能菌群相对丰度呈增加趋势。
证据类型、等级与局限
- 证据类型:动物实验(小鼠脓毒症模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在脓毒症小鼠模型中,MSC和MSC-CM均可减轻组织炎症损伤并调节肠道菌群,MSC-CM表现出优于MSC的优势;作者认为MSC-CM较MSC具有更优优势。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate and compare the regulatory effects of umbilical cord mesenchymal stem cells (MSC) and their conditioned medium (MSC-CM) on gut microbiota of septic mice.
METHODS: Twenty-eight six-to-eight-week-old female C57BL/6J mice were randomly divided into sham operation group (Sham group), sepsis model group (CLP group), sepsis+MSC treatment group (CLP+MSC group) and sepsis+MSC-CM treatment group (CLP+MSC-CM group), with seven mice in each group. The septic mouse model was established by cecal ligation and puncture (CLP). In Sham group, CLP were not performed, and other operations were the same as CLP group. Mice in the CLP+MSC group and CLP+MSC-CM group received 0.2 mL 1×106 MSC or 0.2 mL concentrated MSC-CM via intraperitoneal injection 6 hours after CLP, respectively. Sham group and CLP group were given 0.2 mL sterile phosphate buffer saline (PBS) via intraperitoneal injection. Histopathological changes were evaluated by hematoxylin-eosin (HE) staining and colon length. Levels of inflammatory factors in serum were detected by enzyme-linked immunosorbent assay (ELISA). Phenotype of peritoneal macrophages was analyzed by flow cytometry, and the gut microbiota was analyzed via 16S rRNA sequencing.
RESULTS: Compared with Sham group, significant inflammatory injury in lung and colon was observed, and shorter colon was detected in CLP group (cm: 6.00±0.26 vs. 7.11±0.09), the level of inflammatory cytokine interleukin-1β (IL-1β) in serum was significantly increased (ng/L: 432.70±17.68 vs. 353.70±17.01), the proportion of F4/80+ peritoneal macrophages was increased [(68.25±3.41)% vs. (50.84±4.98)%], while the ratio of F4/80+CD206+ anti-inflammatory peritoneal macrophages was decreased [(45.25±6.75)% vs. (66.66±3.36)%]. The α diversity sobs index of gut microbiota was downregulated significantly (118.50±23.25 vs. 255.70±6.87), the structure of species composition was altered, and the relative abundance of functional gut microbiota related to transcription, secondary metabolites biosynthesis, transport and catabolism, carbohydrate transport and metabolism, and signal transduction were decreased significantly in CLP group (all P < 0.05). Compared with CLP group, upon MSC or MSC-CM treatment, the pathological injury in lung and colon was alleviated to varying extent, the length of colon was increased (cm: 6.53±0.27, 6.87±0.18 vs. 6.00±0.26), the level of IL-1β in serum was downregulated (ng/L: 382.10±16.93, 343.20±23.61 vs. 432.70±17.68), the ratio of F4/80+ peritoneal macrophages was decreased [(47.65±3.93)%, (48.68±2.51)% vs. (68.25±3.41)%], the ratio of F4/80+CD206+ anti-inflammatory peritoneal macrophages was increased [(52.73±5.02)%, (66.38±4.73)% vs. (45.25±6.75)%], and the α diversity sobs index of gut microbiota was increased (182.50±16.35, 214.00±31.18 vs. 118.50±23.25), and the effects of MSC-CM were more significant (all P < 0.05). At the same time, species composition of gut microbiota was rebuilt, and a tendency of increase in relative abundance of functional gut microbiota was observed upon MSC and MSC-CM treatment.
CONCLUSIONS: Both MSC and MSC-CM could alleviate inflammatory injury in tissues, and showed regulatory effects on gut microbiota in septic mouse model, moreover, MSC-CM exhibited superior advantages over MSC.
参考来源
- Fan Y, Yu Z, Lin L, et al. [Regulatory effects of umbilical cord mesenchymal stem cells and their conditioned medium on gut microbiota of septic mice]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 36880237. doi:10.3760/cma.j.cn121430-20221201-01049
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。